Skip to main navigation Skip to search Skip to main content

Pan-drug resistant Providencia rettgeri contributing to a fatal case of COVID-19

  • Patrick M. McGann*
  • , Matthew R. Geringer
  • , Lindsey R. Hall
  • , Francois Lebreton
  • , Elizabeth Markelz
  • , Yoon I. Kwak
  • , Sheila Johnson
  • , Ana C. Ong
  • , Aubrey Powell
  • , Tsigereda Tekle
  • , Yehudit Bergman
  • , Patricia J. Simner
  • , Jason W. Bennett
  • , Robert J. Cybulski
  • , Brian K. White*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

16 Scopus citations

Abstract

Following prolonged hospitalization that included broad-spectrum antibiotic exposure, a strain of Providencia rettgeri was cultured from the blood of a patient undergoing extracorporeal membrane oxygenation treatment for hypoxic respiratory failure due to COVID-19. The strain was resistant to all antimicrobials tested including the novel siderophore cephalosporin, cefiderocol. Whole genome sequencing detected ten antimicrobial resistance genes, including the metallo-β-lactamase blaNDM-1, the extended-spectrum β-lactamase blaPER-1, and the rare 16S methyltransferase rmtB2.

Original languageEnglish
Article number001406
JournalJournal of Medical Microbiology
Volume70
Issue number8
DOIs
StatePublished - 2021

Keywords

  • COVID-19
  • Cefiderocol resistance
  • NDM carbapenemase
  • Providencia rettgeri

Fingerprint

Dive into the research topics of 'Pan-drug resistant Providencia rettgeri contributing to a fatal case of COVID-19'. Together they form a unique fingerprint.

Cite this